人工血管市场规模、份额、增长分析、按原材料、按适应症、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球血管移植市场规模约15亿美元，预测期内（2024-2031年）复合年增长率为7.2%，从2023年的16亿美元增加至2031年的28亿美元。 。

由于心血管疾病盛行率上升、医疗技术进步以及世界人口老化，全球人造血管市场正在经历显着增长。糖尿病、高血压和肥胖症的增加导致血管疾病的增加，从而增加了对血管移植物的需求。合成移植物和生物工程移植物等创新正在提高血管手术的成功率，进一步推动市场发展。微创手术技术的使用也缩短了恢復时间并减少了併发症。此外，末期肾臟病的增加增加了对透析通路手术中使用的血管移植物的需求。新兴市场不断上涨的医疗成本以及政府旨在改善医疗基础设施的措施也有助于市场扩张。然而，血管移植物（尤其是先进的生物工程类型）的高成本以及血栓症和感染疾病等併发症的风险等挑战限制了市场的成长。从地理位置来看，北美由于其先进的医疗基础设施、高昂的医疗成本以及大量患有血管疾病的患者而在血管移植市场占据主导地位。然而，由于医疗保健投资的增加、意识的提高和医疗基础设施的改善，亚太地区预计将成长最快。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 监管分析
• 专利分析
• 原料分析

人造血管市场：依原料分类

• 市场概况
• 聚酯接枝物
• 週边移植物
• 聚氨酯接枝物
• 生物合成移植

人工血管市场：依适应症分类

• 市场概况
• 动脉瘤血管内修復术
  • 腹部主动脉血管瘤修復术
  • 胸主动脉瘤修復术
• 周围血管修復
• 血液透析机通路

人工血管市场：依最终用户分类

• 市场概况
• 医院
• 门诊手术中心

人造血管市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Medtronic
• Terumo
• CR Bard
• B. Braun Melsungen AG
• Cardinal Health
• Endologix
• Lemaitre Vascular
• Cook Medical
• Maquet
• Gore Medical

Global Vascular Grafts Market size was valued at around 1.5 billion in 2022 and is expected to rise from USD 1.6 billion in 2023 to reach a value of USD 2.8 billion by 2031, at a CAGR of 7.2% over the forecast period (2024-2031).

The Global Vascular Grafts Market is experiencing significant growth, driven by the rising prevalence of cardiovascular diseases, advancements in medical technology, and an aging global population. The increasing cases of diabetes, hypertension, and obesity have contributed to a rise in vascular disorders, which has, in turn, escalated the demand for vascular grafts. Technological innovations such as synthetic and bio-engineered grafts are improving the success rates of vascular surgeries, further boosting the market. The use of minimally invasive surgical techniques is also gaining traction, leading to quicker recovery times and fewer complications. Moreover, an increase in end-stage renal diseases has led to a higher demand for vascular grafts used in dialysis access surgeries. The rise in healthcare expenditure in emerging markets, alongside government initiatives aimed at improving healthcare infrastructure, is also contributing to market expansion. However, challenges such as high costs of vascular grafts, especially advanced and bio-engineered types, and risks of complications such as thrombosis and infection are limiting market growth. Geographically, North America dominates the vascular grafts market due to its advanced healthcare infrastructure, high healthcare expenditure, and a large patient population suffering from vascular diseases. However, the Asia-Pacific region is expected to witness the fastest growth due to increasing healthcare investments, growing awareness, and improving medical infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vascular Grafts Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vascular Grafts Market Segmental Analysis

Global Vascular Grafts Market is segmented by Raw Material, Indication, End User, and region. Based on Raw Material, the market is segmented into Polyester Grafts, ePTFE, Polyurethane Grafts, and Biosynthetic Grafts. Based on Indication, the market is segmented into Endovascular Aneurysm Repair, Abdominal Aortic Aneurysms Repair, Thoracic Aortic Aneurysm Repair, Peripheral Vascular, and Hemodialysis Access. Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Vascular Grafts Market

One of the primary drivers of the vascular grafts market is the alarming rise in cardiovascular diseases (CVDs) globally. Sedentary lifestyles, poor dietary habits, and increasing smoking and alcohol consumption have contributed to a higher prevalence of CVDs, including coronary artery disease, aneurysms, and peripheral arterial disease. As CVDs often result in blocked or weakened arteries, vascular grafts become essential to restoring blood flow and preventing severe complications like heart attacks or strokes. The aging population also contributes to this trend, as older adults are more susceptible to vascular diseases. For instance, the World Health Organization (WHO) estimates that cardiovascular diseases account for around 32% of global deaths, emphasizing the need for timely surgical intervention. This rising burden of cardiovascular diseases is driving the demand for vascular grafts, as they play a critical role in bypass surgeries, vascular repairs, and hemodialysis access for patients with end-stage renal disease, further fueling market growth.

Restraints in the Global Vascular Grafts Market

One of the major restraints in the vascular grafts market is the high cost associated with advanced graft materials and surgical procedures. Synthetic and bio-engineered grafts, while offering better outcomes in terms of biocompatibility and longevity, tend to be significantly more expensive than traditional graft materials. The production processes for these advanced grafts involve complex biotechnology and require stringent quality control, leading to higher costs. This financial barrier can be particularly challenging in low- and middle-income countries, where healthcare budgets are limited, and patients may struggle to afford these treatments. Additionally, insurance coverage for vascular graft surgeries may not always be comprehensive, further limiting access to advanced treatments. The high cost can also deter healthcare providers from adopting newer technologies, preferring more traditional, affordable options, despite the clinical benefits offered by cutting-edge vascular graft solutions. This price sensitivity acts as a constraint, slowing the widespread adoption of advanced vascular grafts, especially in resource-limited settings.

Market Trends of the Global Vascular Grafts Market

A notable trend in the vascular grafts market is the growing shift towards bioengineered and biodegradable grafts, driven by the increasing need for biocompatible and long-lasting solutions. Traditional synthetic grafts, such as those made from PTFE (polytetrafluoroethylene) or Dacron, are effective but pose risks of infection, rejection, or thrombosis over time. In response, researchers and manufacturers are focusing on developing grafts that can better integrate with the body's tissues, promoting natural healing and reducing complications. Bioengineered grafts, often made from collagen, elastin, or decellularized tissues, mimic the natural properties of blood vessels, improving their compatibility and performance in vascular surgeries. Biodegradable grafts, on the other hand, are designed to degrade over time, allowing the body's own tissues to regenerate and take over the graft's function. This trend towards more natural, tissue-friendly materials is expected to reduce the risk of long-term complications and improve patient outcomes, making it a key area of focus for future advancements in the vascular grafts market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Patent Analysis
• Raw Material Analysis

Vascular Graft Market, By Raw Material

• Market Overview
• Polyester Grafts
• Eptfe Grafts
• Polyurethane Grafts
• Biosynthetic Grafts

Vascular Graft Market, By Indication

• Market Overview
• Endovascular Aneurysm Repair
  • Abdominal Aortic Aneurysms Repair
  • Thoracic Aortic Aneurysm Repair
• Peripheral Vascular Repair
• Hemodialysis Access

Vascular Graft Market, By End User

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Vascular Graft Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C. R. Bard
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lemaitre Vascular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maquet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments